Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Dont think of fiber as one big number to hit
Gregory Lubiniecki, vice president of oncology clinical research at Merck Research Laboratories, noted in a statement that prognoses are generally poor for this disease and said the company is pleased to offer a new first-line treatment option. The approval was backed by results from the Phase II/III KEYNOTE-483 trial, where Keytruda elicited a significant survival benefit for patients, cutting the risk of death by 21%
Review your plan documents or contact Anthem member services to confirm your referral requirements before booking
Your schedule changes
Jeremy P
US$ 25.97
US$ 24.63
US$ 26.14
US$ 27.19
US$ 22.67
US$ 23.71
US$ 27.16
US$ 24.85
